Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 447

1.

Favorable five-year outcomes for heart failure diagnosed in younger patients without severe comorbidity.

Madelaire C, Gustafsson F, Stevenson LW, Kristensen SL, Køber L, Andersen J, D'Souza M, Torp-Pedersen C, Gislason G, Schou M.

Int J Cardiol. 2020 Jan 23. pii: S0167-5273(19)34977-0. doi: 10.1016/j.ijcard.2020.01.055. [Epub ahead of print]

PMID:
32005452
2.

Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.

Dyhl-Polk A, Vaage-Nilsen M, Schou M, Vistisen KK, Lund CM, Kümler T, Appel JM, Nielsen DL.

Acta Oncol. 2020 Jan 14:1-9. doi: 10.1080/0284186X.2019.1711164. [Epub ahead of print]

PMID:
31931649
3.

A randomised controlled trial of lidocaine infusion on post-operative opioid consumption in patients undergoing robotic colorectal surgery.

Herzog J, Schou M, Jensen KM, Lauridsen JT, Jensen AG.

Dan Med J. 2020 Jan;67(1). pii: A06190342.

PMID:
31908254
4.

A prospective three-year follow-up study on the clinical significance of anti-neuronal antibodies in acute psychiatric disorders.

Schou MB, Sæther SG, Drange OK, Brenner E, Crespi J, Eikenes L, Mykland MS, Pintzka C, Håberg AK, Sand T, Vaaler A, Kondziella D.

Sci Rep. 2019 Dec 31;10(1):35. doi: 10.1038/s41598-019-56934-6.

5.

Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?

Malmborg M, Schmiegelow MDS, Nørgaard CH, Munch A, Gerds T, Schou M, Kistorp C, Torp-Pedersen C, Hlatky MA, Gislason G.

Eur Heart J. 2019 Dec 20. pii: ehz913. doi: 10.1093/eurheartj/ehz913. [Epub ahead of print]

PMID:
31860067
6.

Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18.

Möckel M, de Boer RA, Slagman AC, von Haehling S, Schou M, Vollert JO, Wiemer JC, Ebmeyer S, Martín-Sánchez FJ, Maisel AS, Giannitsis E.

Eur J Heart Fail. 2019 Dec 12. doi: 10.1002/ejhf.1667. [Epub ahead of print]

PMID:
31833168
7.

Sudden death in heart failure: do we understand what we observe?

Schou M, Køber L.

Eur Heart J. 2019 Dec 10. pii: ehz860. doi: 10.1093/eurheartj/ehz860. [Epub ahead of print] No abstract available.

PMID:
31821477
8.

Prognostic utility of diastolic dysfunction and speckle tracking echocardiography in heart failure with reduced ejection fraction.

Hansen S, Brainin P, Sengeløv M, Jørgensen PG, Bruun NE, Olsen FJ, Fritz-Hansen T, Schou M, Gislason G, Biering-Sørensen T.

ESC Heart Fail. 2019 Dec 9. doi: 10.1002/ehf2.12532. [Epub ahead of print]

9.

Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial).

Jürgens M, Schou M, Hasbak P, Kjær A, Wolsk E, Zerahn B, Wiberg M, Brandt NH, Gæde PH, Rossing P, Faber J, Inzucchi S, Gustafsson F, Kistorp CM.

BMJ Open. 2019 Nov 27;9(11):e029098. doi: 10.1136/bmjopen-2019-029098.

10.

Visible-Light-Enabled Aminocarbonylation of Unactivated Alkyl Iodides with Stoichiometric Carbon Monoxide for Application on Late-Stage Carbon Isotope Labeling.

Sardana M, Bergman J, Ericsson C, Kingston LP, Schou M, Dugave C, Audisio D, Elmore CS.

J Org Chem. 2019 Dec 20;84(24):16076-16085. doi: 10.1021/acs.joc.9b02575. Epub 2019 Dec 11.

11.

Prey to predator body size ratio in the evolution of cooperative hunting-a social spider test case.

Grinsted L, Schou MF, Settepani V, Holm C, Bird TL, Bilde T.

Dev Genes Evol. 2019 Nov 25. doi: 10.1007/s00427-019-00640-w. [Epub ahead of print]

PMID:
31768622
12.

The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial.

Bressendorff I, Hansen D, Pasch A, Holt SG, Schou M, Brandi L, Smith ER.

Nephrol Dial Transplant. 2019 Nov 25. pii: gfz234. doi: 10.1093/ndt/gfz234. [Epub ahead of print]

PMID:
31764984
13.

Potential for imaging the high-affinity state of the 5-HT1B receptor: a comparison of three PET radioligands with differing intrinsic activity.

Lindberg A, Arakawa R, Nogami T, Nag S, Schou M, Elmore CS, Farde L, Pike VW, Halldin C.

EJNMMI Res. 2019 Nov 21;9(1):100. doi: 10.1186/s13550-019-0570-1.

14.

Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study.

Jakobsen CB, Lamberts M, Carlson N, Lock-Hansen M, Torp-Pedersen C, Gislason GH, Schou M.

BMC Cancer. 2019 Nov 14;19(1):1105. doi: 10.1186/s12885-019-6314-9.

15.

Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis.

Mueller S, Luderer M, Zhang D, Meulien D, Brach BS, Schou MB.

Alcohol Alcohol. 2020 Feb 7;55(1):63-70. doi: 10.1093/alcalc/agz078.

PMID:
31713583
16.

Development of a 18F-labeled PET radioligand for imaging 5-HT1B receptors: [18F]AZ10419096.

Lindberg A, Nag S, Schou M, Arakawa R, Nogami T, Moein MM, Elmore CS, Pike VW, Halldin C.

Nucl Med Biol. 2019 Nov - Dec;78-79:11-16. doi: 10.1016/j.nucmedbio.2019.10.003. Epub 2019 Oct 22.

PMID:
31678782
17.

Coronary risk stratification of patients with newly diagnosed heart failure.

Hasselbalch RB, Pries-Heje M, Engstrøm T, Sandø A, Heitmann M, Pedersen F, Schou M, Mickley H, Elming H, Steffensen R, Koeber L, Iversen KK.

Open Heart. 2019 Oct 3;6(2):e001074. doi: 10.1136/openhrt-2019-001074. eCollection 2019.

18.

Three-Dimensional Super Resolution Imaging using a Row-Column Array.

Jensen JA, Ommen ML, Oygard SH, Schou M, Sams T, Stuart MB, Beers C, Thomsen EV, Larsen NB, Tomov BG.

IEEE Trans Ultrason Ferroelectr Freq Control. 2019 Oct 21. doi: 10.1109/TUFFC.2019.2948563. [Epub ahead of print]

PMID:
31634831
19.

Catheter ablation for atrial fibrillation is associated with lower incidence of heart failure and death.

Modin D, Claggett B, Gislason G, Hansen ML, Worck R, Johannessen A, Hansen J, Svendsen JH, Pallisgaard JL, Schou M, Køber L, Solomon SD, Torp-Pedersen C, Biering-Sørensen T.

Europace. 2020 Jan 1;22(1):74-83. doi: 10.1093/europace/euz264.

PMID:
31595294
20.

Differences between counties in the prescribing of clozapine.

Schou MB, Drange OK, Sæther SG.

Tidsskr Nor Laegeforen. 2019 Sep 23;139(13). doi: 10.4045/tidsskr.19.0151. Print 2019 Sep 24. Norwegian, English.

21.

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.

McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O'Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjöstrand M, Langkilde AM; DAPA-HF Trial Committees and Investigators.

N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.

PMID:
31535829
22.

"In-loop" carbonylation-A simplified method for carbon-11 labelling of drugs and radioligands.

Ferrat M, Dahl K, Halldin C, Schou M.

J Labelled Comp Radiopharm. 2019 Sep 16. doi: 10.1002/jlcr.3805. [Epub ahead of print]

PMID:
31524295
23.

Fluctuations in nutrient composition affect male reproductive output in Drosophila melanogaster.

Davies LR, Schou MF, Kristensen TN, Loeschcke V.

J Insect Physiol. 2019 Oct;118:103940. doi: 10.1016/j.jinsphys.2019.103940. Epub 2019 Sep 4.

PMID:
31493390
24.

Expression of thermal tolerance genes in two Drosophila species with different acclimation capacities.

Sørensen JG, Giribets MP, Tarrío R, Rodríguez-Trelles F, Schou MF, Loeschcke V.

J Therm Biol. 2019 Aug;84:200-207. doi: 10.1016/j.jtherbio.2019.07.005. Epub 2019 Jul 3.

PMID:
31466754
25.

Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation.

Refsgaard Holm M, Christensen H, Rasmussen J, Johansen ML, Schou M, Faber J, Kistorp C.

ESC Heart Fail. 2019 Oct;6(5):983-991. doi: 10.1002/ehf2.12502. Epub 2019 Aug 20.

26.

Socioeconomic position and one-year mortality risk among patients with heart failure: A nationwide register-based cohort study.

Andersen J, Gerds TA, Gislason G, Schou M, Torp-Pedersen C, Hlatky MA, Møller S, Madelaire C, Strandberg-Larsen K.

Eur J Prev Cardiol. 2020 Jan;27(1):79-88. doi: 10.1177/2047487319865946. Epub 2019 Jul 26.

PMID:
31349771
27.

Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.

Fosbøl EL, Rørth R, Leicht BP, Schou M, Maurer MS, Kristensen SL, Kober L, Gustafsson F.

J Am Coll Cardiol. 2019 Jul 9;74(1):15-23. doi: 10.1016/j.jacc.2019.04.054.

PMID:
31272537
28.

Atrial fibrillation and anticoagulation in patients with breast cancer.

D'Souza M, Smedegaard L, Madelaire C, Bang C, Nielsen D, Torp-Pedersen C, Gislason G, Schou M, Fosbøl E.

Scand Cardiovasc J. 2019 Oct;53(5):247-254. doi: 10.1080/14017431.2019.1638517. Epub 2019 Jul 9.

PMID:
31251080
29.

Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of Life.

Madelaire C, Gustafsson F, Kristensen SL, D'Souza M, Stevenson LW, Kober L, Torp-Pedersen C, Gislason G, Schou M.

JACC Heart Fail. 2019 Jul;7(7):561-570. doi: 10.1016/j.jchf.2019.03.018.

PMID:
31248567
30.

Subtle Phenotype Differences in Psychiatric Patients With and Without Serum Immunoglobulin G Antibodies to Synapsin.

Sæther SG, Vaaler A, Evjenth A, Aune T, Höltje M, Ruprecht K, Schou M.

Front Psychiatry. 2019 Jun 7;10:401. doi: 10.3389/fpsyt.2019.00401. eCollection 2019.

31.

Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF).

Jensen J, Omar M, Kistorp C, Poulsen MK, Tuxen C, Gustafsson I, Køber L, Gustafsson F, Fosbøl E, Bruun NE, Videbæk L, Frederiksen PH, Møller JE, Schou M.

Trials. 2019 Jun 21;20(1):374. doi: 10.1186/s13063-019-3474-5.

32.

Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study.

Zareini B, Rørth R, Holt A, Mogensen UM, Selmer C, Gislason G, Schou M, Køber L, Torp-Pedersen C, Lamberts M, Kristensen SL.

Cardiovasc Diabetol. 2019 Jun 12;18(1):79. doi: 10.1186/s12933-019-0883-4.

33.

Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial (MIRAD trial).

Johansen ML, Schou M, Rossignol P, Holm MR, Rasmussen J, Brandt N, Frandsen M, Chabanova E, Dela F, Faber J, Kistorp C.

Diabetes Obes Metab. 2019 Oct;21(10):2305-2314. doi: 10.1111/dom.13809. Epub 2019 Jul 5.

PMID:
31183945
34.

Polygenic predisposition to breast cancer and the risk of coronary artery disease.

D'Souza M, Schou M, Skals R, Weeke PE, Lee C, Smedegaard L, Madelaire C, Gerds TA, Poulsen HE, Hansen T, Grarup N, Pedersen O, Stender S, Engstrøm T, Fosbøl E, Nielsen D, Gislason G, Køber L, Torp-Pedersen C, Andersson C.

Int J Cardiol. 2019 Sep 15;291:145-151. doi: 10.1016/j.ijcard.2019.05.051. Epub 2019 May 24.

PMID:
31155334
35.

Genetic correlations and their dependence on environmental similarity-Insights from livestock data.

Schou MF, Hoffmann AA, Kristensen TN.

Evolution. 2019 Aug;73(8):1672-1678. doi: 10.1111/evo.13762. Epub 2019 Jun 19.

PMID:
31144765
36.

Changes in left ventricular filling parameters before and after dialysis in patients with end stage renal disease.

Ersbøll M, Raja AA, Warming PE, Nielsen TL, Plesner LL, Dalsgaard M, Schou M, Rydahl C, Brandi L, Iversen K.

Int J Cardiovasc Imaging. 2019 Sep;35(9):1673-1681. doi: 10.1007/s10554-019-01619-4. Epub 2019 May 15.

PMID:
31093896
37.

Comparing thermal performance curves across traits: how consistent are they?

Kellermann V, Chown SL, Schou MF, Aitkenhead I, Janion-Scheepers C, Clemson A, Scott MT, Sgrò CM.

J Exp Biol. 2019 Jun 5;222(Pt 11). pii: jeb193433. doi: 10.1242/jeb.193433.

38.

An echocardiographic substrate for dyspnea identifies high risk patients with type 2 diabetes.

Jørgensen PG, Schou M, Biering-Sørensen T, Mogelvang R, Fritz-Hansen T, Vilsbøll T, Rossing P, Jensen MT.

Int J Cardiol. 2019 Aug 15;289:119-124. doi: 10.1016/j.ijcard.2019.04.093. Epub 2019 May 1.

PMID:
31078354
39.

A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer.

Varrone A, Varnäs K, Jucaite A, Cselényi Z, Johnström P, Schou M, Vazquez-Romero A, Moein MM, Halldin C, Brown AP, Vishwanathan K, Farde L.

J Cereb Blood Flow Metab. 2019 Apr 20:271678X19843776. doi: 10.1177/0271678X19843776. [Epub ahead of print]

PMID:
31006308
40.

Prevalence of early stages of heart failure in an elderly risk population: the Copenhagen Heart Failure Risk Study.

Gaborit FS, Kistorp C, Kümler T, Hassager C, Tønder N, Køber L, Hansen PM, Kamstrup PR, Faber J, Iversen KK, Schou M.

Open Heart. 2019 Feb 27;6(1):e000840. doi: 10.1136/openhrt-2018-000840. eCollection 2019.

41.

Synthesis, 3 H-labelling and in vitro evaluation of a substituted dipiperidine alcohol as a potential ligand for chemokine receptor 2.

Artelsmair M, Miranda-Azpiazu P, Kingston L, Bergare J, Schou M, Varrone A, Elmore CS.

J Labelled Comp Radiopharm. 2019 May 30;62(6):265-279. doi: 10.1002/jlcr.3731.

42.

Evidence for Faster X Chromosome Evolution in Spiders.

Bechsgaard J, Schou MF, Vanthournout B, Hendrickx F, Knudsen B, Settepani V, Schierup MH, Bilde T.

Mol Biol Evol. 2019 Jun 1;36(6):1281-1293. doi: 10.1093/molbev/msz074.

43.

Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab.

Banke A, Fosbøl EL, Ewertz M, Videbæk L, Dahl JS, Poulsen MK, Cold S, Jensen MB, Gislason GH, Schou M, Møller JE.

JACC Heart Fail. 2019 Mar;7(3):217-224. doi: 10.1016/j.jchf.2018.09.001.

PMID:
30819377
44.

Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors.

Lindberg A, Lu S, Nag S, Schou M, Liow JS, Zoghbi SS, Frankland MP, Gladding RL, Morse CL, Takano A, Amini N, Elmore CS, Lee YS, Innis RB, Halldin C, Pike VW.

Nucl Med Biol. 2019 Mar;70:1-13. doi: 10.1016/j.nucmedbio.2019.01.005. Epub 2019 Jan 26.

45.

Relation between invasive hemodynamics and measured glomerular filtration rate by 51Cr-EDTA clearance in advanced heart failure.

Deis T, Balling L, Boesgaard S, Rossing K, Schou M, Oturai P, Wolsk E, Gustafsson F.

Scand J Clin Lab Invest. 2019 May;79(3):194-201. doi: 10.1080/00365513.2019.1576221. Epub 2019 Feb 20.

PMID:
30784338
46.

Incidence of atrial fibrillation in conjunction with breast cancer.

D'Souza M, Smedegaard L, Madelaire C, Nielsen D, Torp-Pedersen C, Gislason G, Schou M, Fosbøl E.

Heart Rhythm. 2019 Mar;16(3):343-348. doi: 10.1016/j.hrthm.2018.10.017. Epub 2019 Jan 29.

PMID:
30709772
47.

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator.

Schou M, Ewing P, Cselenyi Z, Fridén M, Takano A, Halldin C, Farde L.

EJNMMI Res. 2019 Jan 29;9(1):9. doi: 10.1186/s13550-019-0479-8.

48.

The development of a GPR44 targeting radioligand [11C]AZ12204657 for in vivo assessment of beta cell mass.

Jahan M, Johnström P, Selvaraju RK, Svedberg M, Winzell MS, Bernström J, Kingston L, Schou M, Jia Z, Skrtic S, Johansson L, Korsgren O, Farde L, Halldin C, Eriksson O.

EJNMMI Res. 2018 Dec 27;8(1):113. doi: 10.1186/s13550-018-0465-6.

49.

Epitope specificity of anti-synapsin autoantibodies: Differential targeting of synapsin I domains.

Mertens R, Melchert S, Gitler D, Schou MB, Saether SG, Vaaler A, Piepgras J, Kochova E, Benfenati F, Ahnert-Hilger G, Ruprecht K, Höltje M.

PLoS One. 2018 Dec 13;13(12):e0208636. doi: 10.1371/journal.pone.0208636. eCollection 2018.

50.

Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study.

Christensen AM, Bjerre J, Schou M, Jons C, Vinther M, Gislason GH, Johansen JB, Nielsen JC, Petersen HH, Riahi S, Ruwald AC.

Europace. 2019 Mar 1;21(3):465-474. doi: 10.1093/europace/euy268.

PMID:
30535192

Supplemental Content

Support Center